E-LIB Suche - Ergebnisse für: Quintana-Hau, Juan D.

1

Glycosylation differences of an anti-VEGF monoclonal antibo..:

Quiñonez-Alvarado, Mayra G. ; Chávez-Hurtado, Paulina ; Caro-Palomera, Jesús C....
Biologicals. 84 (2023) - p. 101711 , 2023

Link: https://doi.org/10.1016/..

2

Physicochemical characterization of a DMPC-based nanoemulsi..:

Chávez-Hurtado, Paulina ; Pesqueda-Pinedo, Luciano ; Ceballos-Delgadillo, Hector A....
Contact Lens and Anterior Eye. 45 (2022) 2 - p. 101428 , 2022

Link: https://doi.org/10.1016/..

3

Evaluation of the Rheological Properties, Preclinical Safet..:

Palacio-Pastrana, Claudia ; Muñoz-Villegas, Patricia ; Dániel-Dorantes, Fernando...
Medical Devices: Evidence and Research. 15 (2022) - p. 293-305 , 2022

Link: https://doi.org/10.2147/..

4

Pharmacokinetics and Safety of an Intravitreal Humanized An..:

Muñoz-Villegas, Patricia ; Sanchez-Rios, Alejandra ; Quinonez-Alvarado, Mayra G...
Journal of Experimental Pharmacology. 13 (2021) - p. 545-554 , 2021

Link: https://doi.org/10.2147/..

5

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing..:

Olvera-Montaño, Oscar ; Baiza-Duran, Leopoldo ; Quintana-Hau, Juan D...
Drug Design, Development and Therapy. 13 (2019) - p. 3813-3821 , 2019

Link: https://doi.org/10.2147/..

6

Nurr1 is Essential for the Induction of the Dopaminergic Ph..:

Saucedo-Cardenas, Odila ; Quintana-Hau, Juan D. ; Le, Wei-Dong...
Proceedings of the National Academy of Sciences of the United States of America. 95 (1998) 7 - p. 4013-4018 , 1998

Link: https://www.jstor.org/st..

7

Nurr1 is essential for the induction of the dopaminergic ph..:

Saucedo-Cardenas, Odila ; Quintana-Hau, Juan D. ; Le, Wei-Dong...
Proceedings of the National Academy of Sciences. 95 (1998) 7 - p. 4013-4018 , 1998

Link: https://doi.org/10.1073/..

8

Mutagenic consequences of the incorporation of 6-thioguanin..:

Uribe-Luna, Sonia ; Quintana-Hau, Juan D. ; Maldonado-Rodriguez, Rogelio...
Biochemical Pharmacology. 54 (1997) 3 - p. 419-424 , 1997

Link: https://doi.org/10.1016/..

9

Construction and expression of a chimeric gene encoding hum..:

Quintana-Hau, Juan D. ; Uribe-Luna, Sonia ; Espinosa-Lara, Mercedes...
Gene. 163 (1995) 2 - p. 289-294 , 1995

Link: https://doi.org/10.1016/..

10

Novel therapies for proliferative retinopathies:

Martinez-Alejo, Juan Manuel ; Baiza-Duran, Leopoldo Martin ; Quintana-Hau, Juan de Dios
Therapeutic Advances in Chronic Disease. 13 (2022) - p. 204062232211403 , 2022

Link: https://doi.org/10.1177/..

11

Creatinine and Urea Sera Levels Determination after 0.1% Cy..:

González, Jaime R. ; Baiza-Duran, Leopoldo M. ; de Dios Quintana-Hau, Juan..
The Ocular Surface. 3 (2005) - p. S67 , 2005

Link: https://doi.org/10.1016/..

12

Evaluation of the Rheological Properties, Preclinical Safet..:

Palacio-Pastrana, Claudia ; Muñoz-Villegas, Patricia ; Dániel-Dorantes, Fernando...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421612/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Evaluation of the Rheological Properties, Preclinical Safet..:

Palacio-Pastrana, Claudia ; Muñoz-Villegas, Patricia ; Dániel-Dorantes, Fernando...
info:eu-repo/semantics/altIdentifier/doi/10.2147/MDER.S379050. , 2022

Link: https://www.dovepress.co..

14

Pharmacokinetics and Safety of an Intravitreal Humanized An..:

Muñoz-Villegas, Patricia ; Sanchez-Rios, Alejandra ; Quinonez-Alvarado, Mayra G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185251/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Pharmacokinetics and Safety of an Intravitreal Humanized An..:

Muñoz-Villegas, Patricia ; Sanchez-Rios, Alejandra ; Quinonez-Alvarado, Mayra G...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JEP.S308388. , 2021

Link: https://www.dovepress.co..